Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
The Journal of Infectious Diseases|October 3, 2017
Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted VirusJennifer L Spencer, Anismrita Lahon, Linda L Tran, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
H2AX C-Terminal Dipeptide Truncation: A Master Switch of the DNA Damage ResponseFaith M Joseph, Matthew V Holt, John M Jerome, et al.
The American Journal of Pathology|April 10, 2014
Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesisRebeca San Martin, David A Barron, Jennifer A Tuxhorn, et al.
The American Journal of Pathology|January 13, 2011
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimensGustavo E Ayala, Bahar Muezzinoglu, Kai H Hammerich, et al.
The Journal of Clinical Investigation|February 15, 2021
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKTTao Shen, Wei Wang, Wolong Zhou, et al.
Cancer Research|December 6, 2013
FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stromaJulienne L Carstens, Payam Shahi, Susan Van Tsang, et al.
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Pageof 17